PR Newswire
BIRMINGHAM, Ala., July 27, 2021
BIRMINGHAM, Ala., July 27, 2021 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today reported its results of operations for the second quarter ended June 30, 2021.
"Business momentum accelerated in the second quarter of 2021 and resulted in strong revenue and earnings growth in both segments over the same period of 2020 and 2019," said President and Chief Executive Officer of Encompass Health Mark Tarr. "As a result of our strong operating trends and year-to-date performance, we are again raising our full-year 2021 guidance."
Consolidated results
| | | | | Growth | |||||||||
| Q2 2021 | | Q2 2020 | | Dollars | | Percent | |||||||
| (In Millions, Except Per Share Data) | |||||||||||||
Net operating revenues | $ | 1,287.7 | | | $ | 1,074.1 | | | $ | 213.6 | | | 19.9 | % |
Income from continuing operations attributable to Encompass Health per diluted share | 1.13 | | | 0.34 | | | 0.79 | | | 232.4 | % | |||
Adjusted earnings per share | 1.17 | | | 0.31 | | | 0.86 | | | 277.4 | % | |||
Cash flows provided by operating activities | 255.9 | | | 222.3 | | | 33.6 | | | 15.1 | % | |||
Adjusted EBITDA | 278.9 | | | 162.2 | | | 116.7 | | | 71.9 | % | |||
Adjusted free cash flow | 205.6 | | | 168.2 | | | 37.4 | | | 22.2 | % | |||
| Six Months Ended June 30, | | | | | |||||||||
| 2021 | | 2020 | | | | | |||||||
Cash flows provided by operating activities | $ | 414.4 | | | $ | 251.6 | | | $ | 162.8 | | | 64.7 | % |
Adjusted free cash flow | 313.0 | | | 242.8 | | | 70.2 | | | 28.9 | % |
Revenue growth resulted from increased volumes and favorable pricing.
The increase in income from continuing operations attributable to Encompass Health per diluted share and adjusted earnings per share in 2021 primarily resulted from revenue growth.
The increase in year-to-date cash flows provided by operating activities and adjusted free cash flow primarily resulted from revenue growth and the timing of maintenance capital expenditures in 2021.
See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure.
Inpatient rehabilitation segment results
| | | | | Growth | |||||||||
| Q2 2021 | | Q2 2020 | | Dollars | | Percent | |||||||
Net operating revenues: | (In Millions) | |||||||||||||
Inpatient | $ | 976.9 | | | $ | 808.0 | | | $ | 168.9 | | | 20.9 | % |
Outpatient and other | 24.7 | | | 16.5 | | | 8.2 | | | 49.7 | % | |||
Total segment revenue | $ | 1,001.6 | | | $ Werbung Mehr Nachrichten zur Encompass Health Corporation Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News |